Scienmag

JULY 19, 2021

Credit: Andrea Crisanti Testing of an entire Italian town shows antibody levels remain high nine months after SARS-CoV-2 infection, whether symptomatic or asymptomatic.

Antibody 100

Antibody Research Allergies Medicine 100

Scienmag

MAY 27, 2021

New Penn Medicine study shows how T cells compensate when other immune cells go down PHILADELPHIA–Antibodies aren’t the only immune cells needed to fight off COVID-19 — T cells are equally important and can step up to do the job when antibodies are depleted, suggests a new Penn Medicine study of blood cancer patients with […]. (..)

Antibody 54

Antibody Medicine Clinical Trials Clinical Trials 54

Pharmaceutical Technology

FEBRUARY 3, 2023

Additionally, advances in the study of broadly neutralising antibodies (bNAbs) have led to new candidates being studied in early trials. Steven Deeks, professor of medicine at the University of California, San Francisco. This response was also seen in the RV 144 trial, she notes.

Vaccination 293

Vaccination Vaccine Antibody Trials 293

Scienmag

DECEMBER 10, 2020

Using optical biosensor technology, the test provides quantitative measurements of antibodies in blood plasma in less than 20 minutes Credit: Carolyn Lagattuta Researchers at UC Santa Cruz have developed a novel serological assay for the detection of antibodies to SARS-CoV-2, the coronavirus that causes COVID-19.

Antibody 98

Antibody Engineer Development Research 98

Scienmag

JULY 23, 2021

Antibodies capable of neutralizing multiple SARS-CoV-2 strains can inform strategies for broadly protective COVID-19 booster vaccines As the SARS-CoV-2 virus that causes COVID-19 continues to evolve, immunologists and infectious diseases experts are eager to know whether new variants are resistant to the human antibodies that recognized initial versions (..)

Antibody 75

Antibody Protein Vaccination Vaccine 75

Scienmag

AUGUST 18, 2020

Credit: Phil Jones, Senior Photographer, Augusta University A study of 181 patients at 16 sites across the country who test negative for two antibodies long known to cause muscle-weakening myasthenia gravis, found that about 15% test positive for one of two newly discovered antibodies that also attack the point of communication between nerves and muscle. (..)

Antibody 85

Antibody Allergies Medicine 85

The Pharma Data

MAY 22, 2023

DUPIXENT® (DUPILUMAB) LATE-BREAKING PHASE 3 COPD RESULTS PRESENTED AT ATS AND SIMULTANEOUSLY PUBLISHED IN THE NEW ENGLAND JOURNAL OF MEDICINE Regeneron Pharmaceuticals, Inc. The Dupixent Phase 3 results were presented in the 2023 American Thoracic Society (ATS) International Conference session “New England Journal of Medicine and JAMA.

Medicine 52

Medicine Allergies Trials Clinical Trials 52

Drug Discovery World

MARCH 1, 2024

The top stories: FDA approves first medication to reduce allergic reactions The US Food and Drug Administration (FDA) has approved monoclonal antibody Xolair (omalizumab) for immunoglobulin E-mediated food allergy in some adults and children one year or older for the reduction of allergic reactions (Type I).

Drugs 52

Drugs Allergies FDA Approval Medicine 52

Scienmag

JUNE 29, 2021

Six antibody features help protect pregnant women against placental malaria infections, and could be used to identify women at risk of the disease and related complications Six antibody characteristics could help scientists identify which pregnant women are at risk of placental malaria infections, finds a study published today in eLife.

Antibody 65

Antibody Scientist Allergies Medicine 65

Scienmag

FEBRUARY 4, 2021

Researchers at Baylor College of Medicine found that while most individuals responded to respiratory syncytial virus (RSV) natural reinfection with a typical sustained antibody response associated with protection, a few individuals surprisingly responded atypically, not being able to sustain the antibody response, which declined to levels that made (..)

Antibody 42

Antibody Medicine Research Allergies 42

Scienmag

MARCH 31, 2021

New findings from a Michigan Medicine study reveal that antibody testing is predictive of prior COVID-19 infection, and rapid screening methods – even from finger pricks – are effective testing tools. Researchers analyzed antibody tests conducted on more than 500 subjects […].

Antibody 40

Antibody Medicine Research Clinical Trials 40

Scienmag

OCTOBER 6, 2020

Credit: University of Birmingham Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, a new study by immunology experts at the University of Birmingham has found.

Antibody 83

Antibody Allergies Medicine 83

Scienmag

NOVEMBER 2, 2020

2, 2020 – University of Pittsburgh School of Medicine scientists have discovered the fastest way to identify potent, neutralizing human monoclonal antibodies against SARS-CoV-2, the virus that causes COVID-19. Credit: UPMC PITTSBURGH, Nov.

Antibody 40

Antibody Scientist Medicine Allergies 40

Scienmag

MARCH 5, 2021

Scientists at Walter Reed Army Institute of Research, in a collaboration the Duke University, have confirmed that monoclonal antibodies can be an effective tool in the global fight against malaria.

Scientist 74

Scientist Antibody Research Allergies 74

XTalks

FEBRUARY 26, 2024

The class of IgE-mediated food allergies includes 160 foods, with peanuts, milk, eggs, wheat, soy and tree nuts being the most common ones. According to the Centers for Disease Control and Prevention (CDC), almost six percent of people in the US in 2021 had a food allergy. However, the treatment is restricted to peanut allergy.

Allergies 100

Allergies FDA Approval Drugs Protein 100

The Pharma Data

APRIL 3, 2021

The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints.

Clinical Trials 52

Clinical Trials Clinical Trials Medicine Trials 52

Scienmag

SEPTEMBER 11, 2020

Credit: NIAID, 2020 A comprehensive analysis of antibody responses in coronavirus disease 2019 (COVID-19) patients could inform the development of an effective vaccine, according to a study published September 10 in the open-access journal PLOS Pathogens by Chao Wu and Rui Huang of Nanjing University Medical School, and colleagues.

Antibody 61

Antibody Vaccination Vaccine Development 61

Scienmag

AUGUST 17, 2020

. — University of Wisconsin-Madison scientists have discovered that a majority of back-pain patients they tested who were taking opioid painkillers produced anti-opioid antibodies. These antibodies may contribute to some of the negative side effects of long-term opioid use.

Antibody 50

Antibody Scientist Vaccination Vaccine 50

Scienmag

APRIL 22, 2021

SARS-CoV-2 can recruit a haem metabolite to evade antibody immunity Researchers have identified another potential target for neutralizing antibodies on the SARS-CoV-2 Spike protein that is masked by metabolites in the blood.

Antibody 46

Antibody Protein Scientist Research 46

Scienmag

FEBRUARY 25, 2021

Research from the California Institute of Technology shows exactly how antibodies stick to and block the Zika virus, which will inform vaccine development Credit: Image courtesy of Shannon Esswein.

Antibody 52

Antibody Scientist Vaccination Vaccine 52

Scienmag

SEPTEMBER 25, 2020

There is wide variation in the performance of commercial kits for detecting antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published September 24 in the open-access journal PLOS Pathogens by Jonathan Edgeworth and Blair Merrick of Guy’s and St Thomas’ NHS Foundation Trust, Suzanne Pickering (..)

Antibody 67

Antibody Allergies Medicine 67

Scienmag

DECEMBER 16, 2020

Scientists at the Ragon Institute of MGH, MIT and Harvard find that neutralizing antibody potency predicts severe or fatal COVID-19. Of particular interest are neutralizing antibodies, which can block the virus from […].

Antibody 40

Antibody Immune Response Scientist Vaccination 40

The Pharma Data

JULY 11, 2021

3 These data are being presented at the 2021 European Academy of Allergy and Clinical Immunology (EAACI) Hybrid Congress in Krakow, Poland and Madrid, Spain. TAKHZYRO is a fully human monoclonal antibody that specifically binds and decreases plasma kallikrein activity. All antibody titres were low. Contraindication.

Allergies 52

Allergies Antibody Recombinant DNA Technology Production 52

Scienmag

FEBRUARY 10, 2021

Antibodies that react to both ordinary coronaviruses and SARS-CoV-2 are common in the population but don’t neutralize the COVID-19-causing virus PHILADELPHIA — Past exposure to seasonal coronaviruses (CoVs), which cause the common cold, does not result in the production of antibodies that protect against the novel coronavirus SARS-CoV-2, (..)

Antibody 45

Antibody Production Allergies Vaccination 45

Scienmag

DECEMBER 22, 2020

National Institutes of Health researchers have isolated a set of promising, tiny antibodies, or “nanobodies,” against SARS-CoV-2 that were produced by a llama named Cormac. Preliminary results suggest anti-COVID19 nanobodies may be effective at preventing and diagnosing infections Credit: Courtesy of Brody lab NIH/NINDS.

Antibody 52

Antibody Research Allergies Medicine 52

Scienmag

MAY 27, 2021

A special type of antibody is produced in patients who’ve had COVID-19 as well as less-serious coronaviruses that cause colds. LA JOLLA, CA–Even before the COVID-19 pandemic, most people in the United States already had been sick with a coronavirus, albeit a far less dangerous one.

Antibody 50

Antibody Vaccination Vaccine Allergies 50

Scienmag

NOVEMBER 5, 2020

5, 2020)–Children and adults produce different types and amounts of antibodies in response to infection with the new coronavirus, SARS-CoV-2, a new study from researchers at Columbia University Vagelos College of Physicians and Surgeons has found. NEW YORK, NY (Nov.

Antibody 40

Antibody Immune Response Research Allergies 40

Scienmag

NOVEMBER 3, 2020

Brigham investigators have identified patients who cleared the disease faster and had a persistent antibody response, with important implications for immunity Boston, MA — One of the pressing questions about COVID-19 remains: How long does immunity last? One key indicator of immunity is the presence of virus-specific antibodies.

Antibody 43

Antibody Allergies Vaccination Vaccine 43

Scienmag

JUNE 23, 2021

A study by the University of South Florida Health and Tampa General Hospital is among the first to assess effectiveness of monoclonal antibodies in a practical setting when given early to patients at high risk for severe COVID-19 TAMPA, Fla. June 24, 2021) — A newly published study by the University of South Florida Health […].

Antibody 40

Antibody Allergies Medicine 40

Scienmag

SEPTEMBER 25, 2020

A combination antibody treatment for preventing COVID-19 illness in individuals who have had sustained exposure to someone with the virus is being studied by researchers at The University of Texas Health Science Center at Houston (UTHealth). The clinical trial is enrolling patients at Harris Health System’s Lyndon B. Johnson Hospital.

Antibody 43

Antibody Clinical Trials Clinical Trials Trials 43

Scienmag

JANUARY 25, 2021

OHSU study has important implications for vaccines, diagnosis of COVID-19 A new study demonstrates that antibodies generated by the novel coronavirus react to other strains of coronavirus and vice versa, according to research published today by scientists from Oregon Health & Science University.

Antibody 40

Antibody Scientist Vaccination Vaccine 40

Scienmag

MARCH 18, 2021

New study is the first long-term seroprevalence study from Wuhan, China involving over 9,000 residents who were tested for antibodies after the Wuhan lockdown lifted in April, then again in June and in October-December 2020.

Antibody 40

Antibody Allergies Medicine 40

Scienmag

JUNE 3, 2021

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2)

Antibody 41

Antibody Vaccination Vaccine Allergies 41

Scienmag

APRIL 9, 2021

The structural revelation could have implications as a therapeutic target in all SARS-CoV-2 variants Credit: Kelly Lab/Penn State A tiny protein of SARS-CoV-2, the coronavirus that gives rise to COVID-19, may have big implications for future treatments, according to a team of Penn State researchers.

Antibody 93

Antibody Protein Scientist Research 93

Scienmag

DECEMBER 23, 2020

Certain antibody alterations may prevent their passage from mother to fetus BOSTON – Recent analyses indicate that pregnant women and newborns may face elevated risks of developing more severe cases of COVID-19 following SARS-CoV-2 infection.

Antibody 40

Antibody Research Development Allergies 40

Scienmag

OCTOBER 9, 2020

Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study.

In-Vitro 40

In-Vitro Antibody Allergies Medicine 40

Scienmag

SEPTEMBER 15, 2020

A study on the effectiveness of multiple treatments, including laboratory-made antibodies, at preventing mild COVID-19 from advancing to severe illness in the outpatient setting is underway by researchers at The University of Texas Health Science Center at Houston (UTHealth).

Antibody 40

Antibody Trials Clinical Trials Clinical Trials 40